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Abstract An adverse fetal environment leads to smaller
kidneys, with fewer nephrons, which might predispose an
individual to the development of kidney disease and hyper-
tension in adult life. In a prospective cohort study among
1,072 children followed from early fetal life onward, we
examined whether maternal smoking during pregnancy, as a
significant adverse fetal exposure, is associated with fetal
(third trimester of pregnancy, n=1,031) and infant kidney
volume (2 years of age, n=538) measured by ultrasound.
Analyses were adjusted for various potential confounders.
Among mothers who continued smoking, we observed dose-
dependent associations between the number of cigarettes
smoked during pregnancy and kidney volume in fetal life.
Smoking less than five cigarettes per day was associated
with larger fetal combined kidney volume, while smoking
more than ten cigarettes per day tended to be associated with
smaller fetal combined kidney volume (p for trend: 0.002).
This pattern was not significant for kidney volume at the age
of 2 years. Our results suggest that smoking during
pregnancy might affect kidney development in fetal life with
a dose-dependent relationship. Further studies are needed to
assess the underlying mechanisms and whether these differ-
ences in fetal kidney volume have postnatal consequences
for kidney function and blood pressure.
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Introduction
The developmental plasticity hypothesis suggests that
various adverse intra-uterine exposures lead to persistent
fetal developmental adaptations. These adaptations may be
beneficial in the short term, but may have adverse
consequences in postnatal life [1]. Also, they may lead to
smaller kidneys with a reduced number of nephrons, which
in turn lead to glomerular hyperfiltration and sclerosis,
predisposing the individual to renal damage and subsequent
development of higher blood pressure, impaired kidney
function and end-stage kidney disease in adulthood [2].
This hypothesis is supported by many studies showing the
associations between low birth weight and cardiovascular
disease and chronic renal failure [3–5]. Low birth weight is
also associated with impaired renal growth, raised blood
pressure and impaired renal function [5–9]. Thus far, the
specific adverse fetal exposures and mechanisms under-
lying these associations are not known. Maternal smoking
is a very important modifiable adverse fetal exposure in
western countries and leads to a decrease of 150–200 g in
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the offspring’s birth weight [10]. Maternal smoking during
pregnancy may also have both direct and indirect adverse
effects on fetal kidney development. Several studies
suggested that maternal smoking during pregnancy might
also be associated with higher blood pressure in the
offspring, independent of birth weight [11], which might
be explained by adverse kidney development [12].
For the present study, we hypothesised that maternal
smoking during pregnancy, as a specific adverse fetal
exposure, affects early kidney growth. In a population-
based prospective cohort study, among 1,072 mothers and
children, we evaluated the associations between maternal
smoking during pregnancy and kidney volume in fetal life
and infancy, both in those mothers who smoked during the
first trimester only and in those who continued smoking
throughout pregnancy.
Patients and methods
Design
This study was embedded in the Generation R Study, a
population-based prospective cohort study on fetal life to
young adulthood in Rotterdam, The Netherlands [13, 14].
Detailed assessments were conducted in a subgroup of
Dutch children and their parents. Mothers who were already
participating during pregnancy were asked to participate in
a subcohort for additional detailed renal and cardiovascular
measurements. These women were all enrolled before a
gestational age of 24 weeks. In total, 80% of these mothers
were willing to participate in the subcohort. Data on
smoking during pregnancy were available from prospec-
tively collected questionnaires. For the present study,
kidney measurements were performed at a gestational age
of 30 weeks and at the postnatal age of 24 months. Written
informed consent was obtained from all participants. The
Medical Ethics Committee of the Erasmus Medical Center
Rotterdam approved the study.
Population for analysis
In total 1,232 women were enrolled in the subgroup study.
Twin pregnancies (n=15) and pregnancies leading to
perinatal death (n=2) were excluded from the analysis,
leading to 1,215 singleton live births. No renal or
uterovesical anomalies other than mild pyelectasis over
10 mm (n=3) were present in our study. Information about
smoking during pregnancy was not available in 110
subjects. Of the remaining 1,105 mothers, fetal kidney
characteristics were successfully measured in 1,031 sub-
jects (93%). In total, 67% (n=740) of the mothers and
children with information about smoking during pregnancy
participated in the follow-up study at the age of 2 years,
with successful kidney measurements in 73% of these
children (n=538). Missing data were mostly due to crying
and oppositional behaviour.
In total 1,072 (97%) had at least one complete kidney
measurement.
Maternal smoking during pregnancy
Information about active smoking was obtained by postal
questionnaires in the first, second and third trimester of
pregnancy. Response rates for these questionnaires were
90%, 93% and 92% respectively [15]. Active maternal
smoking at enrolment was assessed in the first question-
naire by asking whether the mother smoked in pregnancy
(no, in the first trimester only, or whether she continued
smoking during the first trimester). In the second and third-
trimester questionnaires, mothers were asked whether they
had smoked in the past 2 months (no, yes). Among the
smoking mothers, the number of cigarettes was classified
into different categories: less than five cigarettes per day;
five to ten cigarettes per day; and more than ten cigarettes
per day. Dose–response analyses for the first trimester only
and for mothers who continued smoking were based on the
first and third trimester questionnaires respectively.
Kidney measurements
All ultrasound examinations were performed using an ATL-
Philips Model HDI 5000 (Seattle, WA, USA) equipped
with a 5.0-MHz, high-frequency curved array transducer.
Ultrasound examinations were carried out in a dedicated
and well-equipped research centre in the third trimester of
pregnancy. Fetal left and right kidney biometrics were
assessed. In a sagittal plane, the maximum longitudinal
kidney length was measured placing the callipers on the
outer edges of the caudal and cranial side. Antero-posterior
and transverse kidney diameter were measured perpendic-
ular to each other, from the one outer edge to the other, in
an axial plane. The cross-sectional area in which the kidney
appeared symmetrically round at its maximum width was
used. The images were sufficiently magnified to ensure
optimal measurements [16]. Postnatally, two-dimensional
ultrasounds of the kidneys were performed in children at
the age of 24 months. The examination was carried out in a
quiet room with the child quietly awake in a supine
position. This position was standardised to prevent differ-
ences according to the position [16, 17]. The kidney was
identified in the sagittal plane along its longitudinal axis.
Measures of maximal bipolar kidney length, width and
depth were obtained from both the left and the right kidney.
Kidney width and depth were measured at the level of the
kidney hilum [16, 17]. Both fetal and postnatal kidney
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volumes were calculated using the equation of an ellipsoid:
volume (cm3)=0.523×length (mm)×width (mm)×depth
(mm). Left and right kidney volumes were added for the
combined kidney volume (cm3) [18].
Intra- and inter-observer reproducibility
Two well-trained, experienced sonographers performed
all measurements. Quality checks were frequently carried
out and feedback was provided to minimise inter-
operator differences. We have previously shown that
kidney characteristics can be reliably measured in
children [19]. The intraobserver interclass correlation
coefficients (ICC) ranged from 0.93 (left and right kidney
width and right renal thickness) to 0.99 (left kidney
length) and interobserver ICC ranged from 0.64 (right
kidney thickness) to 0.90 (right kidney length), indicating
good reproducibility.
Covariates
Maternal height was measured at enrolment. Information on
maternal pre-pregnancy weight and maternal educational
level was assessed using self-reported questionnaires. We
defined maternal weight gain as the difference between
weight at enrolment and weight in the third trimester of the
pregnancy, as described before [20]. The educational level
of the father and the family income were also assessed
using questionnaires at enrolment. Total daily energy intake
was established using semiquantitative food frequency
questionnaires in the first trimester of the pregnancy. Exact
gestational age was established using fetal biometry
measured in the first trimester of the pregnancy [21]. Fetal
biometrics including head circumference (HC), abdominal
circumference (AC) and femur length (FL) were measured
using standardised ultrasound procedures in the third
trimester of the pregnancy and estimated fetal weight
(EFW) was calculated using the formula by Hadlock:
EFW (g)=10×(1.326 – 0.00326×AC×FL+0.0107×HC+
0.0438×AC+0.158×FL) [22]. Fetal biometrics was meas-
ured at the same visit as the fetal kidney measurement. Date
of birth, birth weight and sex were obtained from the
midwife and from the hospital registries. Postnatal height
and weight were measured at the same visit as the postnatal
kidney measurement.
Statistical methods
Differences in maternal and offspring characteristics among
the non-smoking, the first trimester only and the continuing
smokers were assessed using t tests and non-parametric
tests for independent samples. Associations between mater-
nal smoking, both first trimester only and continued
smoking, and kidney volume were assessed using multiple
linear regression models. We adjusted for covariates that
changed the effect estimate of smoking during pregnancy
on kidney volume by more than 10%, when added to the
baseline model, including gender, age and estimated fetal
weight. All regression models were adjusted for fetal sex,
maternal height and weight before pregnancy, maternal
weight gain during pregnancy, total daily caloric intake,
maternal and paternal educational level, and household
income. We further adjusted the analyses focussing on fetal
kidney volume for estimated fetal weight in the third
trimester of the pregnancy (30 weeks) and gestational age at
the visit. The models focussing on postnatal kidney volume
were additionally adjusted for age, weight and height at the
visit. Systolic and diastolic blood pressure at intake, parity,
maternal alcohol use during pregnancy and folic acid
supplement use did not materially change the effect
estimate.
Subsequently, using similar models we examined the
associations between the number of cigarettes smoked and
kidney volumes. Missing values in covariates ranged from
0 to 10%, except for paternal educational level (13.9%) and
daily total energy intake (14.7%), and were imputed as the
mean for continuous variables and a separate category for
categorical variables. Since no differences in the main
results were observed between data on complete and
imputed analyses, we only present data on imputed
analyses. Tests for trends were performed using multiple
non-linear regression analyses, including a squared term of
the smoking during pregnancy categories, using the non-
smoking group as the reference group. All measures of
association are presented with their 95% confidence
intervals (95% CI). We considered a p value lower than
0.05 to be statistically significant. All statistical analyses
were performed using the Statistical Package for the Social
Sciences version 15.0 for Windows (SPSS, Chicago, IL,
USA).
Results
Subject characteristics are presented in Table 1. The percent-
age of boys was 52.1%. The overall median maternal age
was 31.8 (95% range: 23.5–37.7) years. The study group
comprised 31 children who were born with a small size for
gestational age (birth weight less than −2 SDS for gestational
age), 37 children with a birth weight less than 2,500 g, and
41 children who were born preterm. Table 2 shows all
kidney characteristics measured in the third trimester of
pregnancy and at the postnatal age of 2 years.
Table 3 gives the adjusted associations between maternal
smoking during pregnancy and fetal and postnatal com-
bined volume. Overall, compared with non-smoking, no
Pediatr Nephrol (2011) 26:1275–1283 1277
significant associations between first trimester only smok-
ing, or continued smoking during pregnancy, and fetal
kidney volume were observed. Smoking during the first
trimester only, but not continued smoking, was positively
associated with combined kidney volume at the age of
2 years. Among first trimester only smokers, we did not
observe any consistent dose–response associations between
the number of cigarettes smoked and the combined kidney
volume in fetal life or at the age of 2 years (data not
shown).
Table 1 Subject characteristics (n=1,072)
Smoking during pregnancy (N=1,072)
Non-smoking (n=805) First trimester only (n=101) Continued smoking (n=166)
Maternal characteristics
Age (years) 31.7 (24.9–37.7) 30.8 (21.8–38.4) 30.4 (21.3–37.2)*
Height (cm) 171.2 (6.3) 170.7 (6.7) 169.6 (6.2)**
Pre-pregnancy weight (kg) 69.5 (12.9) 66.5 (10.4)** 67.7 (13.3)
Weight gain during pregnancy (kg) 8.0 (2.0–14.0) 9.0 (3.0–16.1)** 8.0 (1.0–14.7)
Systolic blood pressure (mmHg) 118.7 (12.8) 118.4 (13.8) 118.0 (12.4)
Diastolic blood pressure (mmHg) 69.9 (10.1) 68.2 (9.2) 67.6 (9.3)**
Parity≥1 (%) 39.4 27.7* 44.6
Highest education (%)
Primary school 1.2 5.0** 6.2**
Secondary school 30.7 37.6** 56.8**
Higher education 68.1 57.4** 37.0**
Household income (%)
<1,200 Euro 1.5 1.2 12.9**
1,200–1,600 Euro 4.5 4.7 9.3**
>1,600 Euro 94.0 94.1 77.8**
Alcohol use during pregnancy (%) 51.8 54.9 52.2
Total daily energy intake (kcal) 2,109 (496) 2,147 (526) 2,244 (492)**
Folic acid supplement use (%) 93.1 89.0 78.2**
Paternal characteristics
Age of biological father 33.6 (26.9–42.8) 32.8 (25.5–41.1) 33.1 (23.0–41.8)*
Highest education (%)
Primary school 2.7 1.2 10.4**
Secondary school 31.2 32.5 59.7**
Higher education 66.1 66.3 29.9**
Third-trimester fetal characteristics
Gestational age at assessment (weeks) 30.4 (28.8–32.2) 30.3 (28.8–31.9) 30.2 (28.6–31.7)
Head circumference (mm) 287 (266–307) 288 (267–306) 283 (263–305)**
Abdominal circumference (mm) 266 (239–293) 267 (237–299) 262 (233–295)*
Femur length (mm) 57 (53–63) 57 (52–62) 56 (51–61)**
Estimated fetal weight (g) 1,619 (1,264–2,118) 1,643 (1,181–2,119) 1,527 (1,167–2,094) **
Birth characteristics
Gestational age (weeks) 40.3 (37.1–42.1) 39.9 (36.2–42.0) 40.1 (36.8–42.1)
Male (%) 51.9 44.1 57.8
Birth weight (g) 3,580 (2,660–4,350) 3,570 (2,487–4,643) 3,412 (2,342–4,243)**
Low birth weight (% <2,500 g) 3.0 4.9 6.1*
Small size for gestational age (% ≤2 SD) 2.2 2.9 6.6*
Preterm birth (%) 4.1 5.9 4.9
Values are means (SD) or medians (95% range)
*p<0.05
**p<0.01
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Among mothers who continued smoking during pregnancy,
we observed a dose-dependent association between the number
of cigarettes smoked during the third trimester and the fetal
combined kidney volume (Table 3). Compared with non-
smoking, smoking less than five cigarettes per day was
associated with larger fetal combined kidney volume. Smoking
more than ten cigarettes per day tended to be associated with
smaller combined kidney volume.We observed non-significant
associations between the number of cigarettes smoked during
pregnancy and kidney volumes at the age of 2 years.
Figure 1 shows that the regression coefficients of
multiple linear regressions on combined kidney volume
and estimated fetal weight are affected separately by
smoking throughout pregnancy. Estimated fetal weight
proportionally decreased with the number of cigarettes
smoked per day (p value for trend: 0.01). Combined kidney
volume, however, was larger in offspring of mothers who
smoked less than five cigarettes per day, and became
smaller with increasing numbers of cigarettes smoked per
day (p value for trend: 0.003). Figure 2 shows the
associations between continued maternal smoking during
pregnancy and postnatal combined kidney volume and
body weight. No significant associations were observed.
Discussion
Results from this population-based prospective cohort study
from early fetal life onward suggest that first-trimester-only
Table 3 Maternal smoking during pregnancy and fetal and postnatal
kidney volume
Combined kidney volume
Smoking during
pregnancy
30 weeks’ gestation
(n=1,031)
2 years (n=538)
No smoking Reference (n=769) Reference (n=415)
First trimester only
(overall)
−0.06 (−1.12 , 0.99)
(n=98)
3.92 (0.24–7.61)*
(n=49)
Continued smoking
(overall)
0.25 (−0.65, 1.15)
(n=164)
0.18 (−3.08 , 3.43)
(n=74)
Number of cigarettes smoked per day
<5/day 1.71 (0.51 , 2.92)**
(n=76)
0.49 (−3.81 , 4.78)
(n=32)
5–10/day −0.55 (−1.99 , −0.89)
(n=55)
−0.48 (−5.66 , 4.71)
(n=24)
>10/day −1.95 (−3.73 , −0.16)*
(n=32)
−2.33 (−8.65 , 4.00)
(n=15)
p value for trend 0.002 0.331
Values are regression coefficients (95% CI) and reflect the difference
in kidney volume for different categories of maternal smoking during
pregnancy. All regression models were adjusted for fetal sex, maternal
height and weight before pregnancy, maternal weight gain during
pregnancy, total daily caloric intake, maternal and paternal educational
level, and household income. The models for fetal kidney size were
also adjusted for estimated fetal weight and gestational age at the visit.
The postnatal kidney analyses were additionally adjusted for age,
weight and height at the visit
Tests for trend were calculated using non-linear regression models,
including a squared term of the number of cigarettes smoked during
the pregnancy categories
*p<0.05, **p<0.01
Table 2 Fetal and postnatal kidney characteristics
30 weeks’ gestation
(n=1,031)
2 years
(n=538)
Age at assessment
(weeks)
30.2 (28.8–32.1)a 109 (103–120)b
Left kidney structures
Length (mm) 39.0 (33.0–45.2) 66.3 (57.3–76.7)
Width (mm) 21.0 (17.0–26.0) 30.2 (25.6–36.3)
Depth (mm) 22.0 (18.0–27.0) 30.3 (25.5–36.4)
Volume (cm3) 9.6 (6.0–14.9) 31.7 (22.7–46.3)
Right kidney structures
Length (mm) 39.0 (33.0–45.0) 64.7 (55.9–75.3)
Width (mm) 22.0 (18.0–27.0) 30.6 (26.3–35.7)
Depth (mm) 23.0 (18.9–28.0) 31.7 (26.9–38.2)
Volume (cm3) 10.2 (6.4–16.4) 32.2 (23.6–47.0)
Combined kidney
volume (cm3)
19.9 (12.6–30.7) 64.0 (48.5–93.6)
Values are medians (95% range)
a Gestational age during pregnancy at assessment
b Postnatal age at assessment
Fig. 1 Bars represent regression coefficients (95% CI) and reflect the
difference in the standard deviation scores (SDS) of the fetal kidney
volume and the estimated fetal weight for different numbers of
cigarettes smoked continuously throughout pregnancy. All regression
models were adjusted for fetal sex, gestational age at the visit,
maternal height and weight before pregnancy, maternal weight gain
during pregnancy, systolic and diastolic blood pressure at intake,
parity, maternal alcohol use during pregnancy, folic acid supplement
use, total daily caloric intake, maternal and paternal educational level,
and household income. The model for estimated fetal weight was
adjusted for the same covariates
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smoking is not consistently associated with kidney volume
in fetal life and infancy, whereas continued smoking during
pregnancy does affect kidney volume in fetal life. The
effect size and direction depends on the number of
cigarettes smoked. Smoking less than five cigarettes per
day was associated with a larger fetal combined kidney
volume. This association was not significant at the age of
2 years. Smoking more than ten cigarettes per day tended to
be associated with a smaller combined kidney volume in
both fetal and postnatal life.
Maternal smoking during pregnancy is an important
modifiable adverse fetal exposure leading to various
pregnancy complications in western countries [10, 23].
The recently demonstrated associations between maternal
smoking during pregnancy and high blood pressure in the
offspring suggest that fetal exposure to smoking has
permanent renal and cardiovascular consequences [24].
We showed associations between continued smoking dur-
ing pregnancy and fetal kidney volume, but not postnatal
kidney volume. The effect of continued smoking during
pregnancy was dependent on the number of cigarettes
smoked. This suggests a differential effect of maternal
smoking during pregnancy, depending on the specific
period of exposure and the number of cigarettes smoked.
The main strength of our study is the prospective design
from early fetal life onward and the size of the population-
based cohort. Our analyses were based on more than 1,500
complete kidney ultrasounds. The size of the cohort
enabled us to assess the associations between the number
of cigarettes smoked during pregnancy and the kidney
volume. The ultrasound measurements were carried out by
two sonographers with good reproducibility.
Of all children with available data on maternal smoking
during pregnancy, 67% participated in the follow-up
measurements at the age of 2 years. Subjects who did not
visit the research centre in postnatal life did not differ with
regard to fetal kidney volume from the original sample.
However, more mothers in this group continued smoking
during pregnancy and mothers were less well educated than
those in the original sample. This selective loss to follow-up
might have led to the loss of power in the postnatal analyses,
and possibly selection bias. Although we performed a
meticulous adjustment, especially regarding socioeconomic
status, residual confounding might still have been an issue
because of the observational design of the study.
Another reason for the lack of associations in postnatal
life might be that kidney measurements are more difficult at
the age of 2 years, possibly introducing random error,
which leads to a reduction in statistical power. One might
also assume that some hypertrophy of nephrons is already
ongoing in kidneys with lower nephron numbers (i.e.
smaller fetal kidney volume) due to heavy smoking
mothers, decreasing the difference in kidney volume over
time. The increased kidney volume in mothers who smoked
less than five cigarettes per day might have disappeared
because of the return to the normal kidney growth curve in
postnatal life, while the reduced body size catches up.
Using questionnaires for collecting data on smoking
behaviour might have resulted in underestimation of the
number of cigarettes smoked per day, since some individ-
uals might not report their smoking behaviour accurately.
We did not measure cotinine levels to check the smoking
status in the mothers. Although assessing maternal smoking
during pregnancy seems to be a valid method, misclassifi-
cation may occur [25, 26]. Another limitation might be that
the present study was performed in a healthy population-
based cohort. The absolute numbers of subjects with low
birth weight and preterm birth were small. Therefore, the
generalisability of our results to preterm or low birth weight
children is limited.
One other study among 34 subjects showed that maternal
smoking during pregnancy leads to a different fetal kidney
growth pattern compared with non-smoke-exposed sub-
jects. This study suggested that reduction in kidney growth
is present in the third trimester of pregnancy, resulting in
relatively thinner kidneys [12]. This is in line with our
finding that smoking more than ten cigarettes in the third
trimester negatively affects the fetal and infant kidney
volume. To our knowledge, no other studies have examined
the associations between maternal smoking during preg-
nancy and kidney size.
Fig. 2 Bars represent regression coefficients (95% CI) and reflect the
difference in SDS of the kidney volume at 2 years of age and weight
at 2 years of age for different numbers of cigarettes smoked
continuously throughout pregnancy. All regression models were
adjusted for sex, age at the visit, maternal height and weight before
pregnancy, maternal weight gain during pregnancy, systolic and
diastolic blood pressure at intake, parity, maternal alcohol use during
pregnancy, folic acid supplement use, total daily caloric intake,
maternal and paternal educational level, and household income. The
model for weight at 2 years of age was adjusted for the same
covariates
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The mechanisms underlying the associations between
smoking during pregnancy and fetal and infant kidney
volume found in this study are not known. Animal studies
showed that nicotine has both a vasodilatory and a vaso-
constrictive effect on the vasculature, depending on the
dose [27–29]. A higher dose of nicotine was associated
with vasoconstriction and might partly explain our findings
of smaller kidney size when large numbers of cigarettes are
smoked during pregnancy [29]. The larger kidneys among
subjects exposed to less than five cigarettes per day could
be explained by the vasodilatory effect of nicotine on the
renal vasculature. Animal studies showed the vasodilatory
effects of low-dose nicotine in the kidney as pre-constricted
kidney vasculature [30, 31]. Maternal smoking during
pregnancy affects fetal growth in different trimesters of
pregnancy, with the largest effect in the third trimester.
Results suggest that smoking during pregnancy preferen-
tially affects peripheral tissues [25]. The vasodilatory effect
of nicotine on the kidney vasculature might lead to
increased kidney volume, despite the negative effect on
the estimated fetal weight. However, further studies are
needed to elucidate the vasoactive effects of nicotine in
growth-restricted subjects.
Another possible mechanism could be the role of the renin–
angiotensin system (RAS). It has been shown that an intact
RAS is needed for normal kidney development and disruption
is associated with a lower glomerular number, decreased renal
function and increased adult blood pressure [32, 33]. It also
has been shown that smoking during pregnancy alters the
AT1/AT2 receptor ratio in renal tissue [34]. This could partly
explain our findings that smoking more than ten cigarettes
per day is associated with smaller fetal kidney volume.
Further studies are needed to evaluate the effect of maternal
smoking during pregnancy on RAS in humans.
The associations between low birth weight and hyper-
tension, impaired renal function and end-stage renal disease
in adulthood are well established [3, 6, 9, 35, 36]. Smaller
kidneys with a reduced number of nephrons in low birth
weight children might lead to hyperfiltration resulting in
glomerular sclerosis [2, 37–40]. This may predispose the
individual to renal damage and development of higher
blood pressure, impaired kidney function and end-stage
kidney disease in adulthood. This hypothesis is supported
by animal studies that have shown that various adverse
intrauterine environmental exposures, such as low protein
intake, lead to fetal growth retardation and smaller kidney
size with a lower nephron number [41–43]. Postmortem
studies in humans showed that a lower nephron number is
associated with both low birth weight and hypertension
[37, 39, 44, 45].
Newborn kidney volume has been shown to be a
surrogate of total nephron number. This was shown in 15
infants who died before 3 months of age, in whom an
ultrasound was performed in the first 2 days of life. There
was a strong and direct relationship between kidney mass
and nephron number [46]. Since the nephron number varies
between 250,000 and 2,000,000 per kidney and nephron
development ceases after birth [44, 47], these findings
suggest that early kidney development might be an under-
lying mechanism for the associations between maternal
smoking during pregnancy and increased blood pressure in
later life. Whether the differences in kidney volume due to
smoking during pregnancy found in this study also
correlate with nephron number needs to be studied.
Conclusion
Our results suggest that maternal smoking during preg-
nancy might be associated with altered kidney volume in
late pregnancy, but not in infancy. The direction and size of
the effect depends on the number of cigarettes smoked.
These results should be considered as hypothesis-
generating. Further studies are needed to identify the
underlying mechanisms and to assess whether these
changes in kidney size in early life are related to renal
function and high blood pressure development in later life.
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